Trazodone
(OHHDIOKRWWOXMT-UHFFFAOYSA-N)
Structure
- SMILES
- Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2.Cl
- Molecular Formula:
- C19H23Cl2N5O
- Molecular Weight:
- 408.325
- Log P:
- 3.1666
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 1
- TPSA:
- 45.78
- CAS Number(s):
- 19666-36-5; 25332-39-2
Synonym(s)
1.
Trazodone
2.
AF-1161
3.
Apo-Trazodone
4.
Deprax
5.
Desyrel
6.
Gen-Trazodone
7.
Molipaxin
8.
Novo-Trazodone
9.
Nu-Trazodone
10.
PMS-Trazodone
11.
Ratio-Trazodone
12.
Thombran
13.
Tradozone
14.
Trazodon Hexal
15.
Trazodon-Neuraxpharm
16.
Trazodone Hydrochloride
17.
Trazon
18.
Trittico
19.
AF 1161
20.
AF1161
21.
Apo Trazodone
22.
Gen Trazodone
23.
Novo Trazodone
24.
Nu Trazodone
25.
PMS Trazodone
26.
Ratio Trazodone
27.
RatioTrazodone
28.
Trazodon Neuraxpharm
29.
TrazodonNeuraxpharm
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 83 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 2 | Priapism | FAERS: 73 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Dizziness | FAERS: 45 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 4 | Headache | FAERS: 32 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 5 | Nausea | FAERS: 26 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 6 | Anxiety | FAERS: 24 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Feeling abnormal | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Somnolence | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Fatigue | FAERS: 20 | US FAERS | |
| 10 | Product quality issue | FAERS: 17 | US FAERS | |
| 11 | Product substitution issue | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 12 | Tremor | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 13 | Vomiting | FAERS: 17 | US FAERS | |
| 14 | Erectile dysfunction | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Overdose | FAERS: 15 | US FAERS | |
| 16 | Palpitations | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 17 | Pharmaceutical product complaint | FAERS: 13 | US FAERS | |
| 18 | Asthenia | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Chest Pain | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Medication Error | FAERS: 12 | US FAERS | |
| 21 | Drug dispensing error | FAERS: 11 | US FAERS | |
| 22 | Pain | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Serotonin Syndrome | FAERS: 11 | US FAERS | |
| 24 | Disorientation | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Drug ineffective for unapproved indication | FAERS: 10 | US FAERS | |
| 26 | Erection increased | FAERS: 10 | US FAERS | |
| 27 | Malaise | FAERS: 10 | US FAERS | |
| 28 | Suicide attempt | FAERS: 10 | US FAERS | |
| 29 | Choking | FAERS: 9 | US FAERS | |
| 30 | Drug withdrawal syndrome | FAERS: 9 | US FAERS | |
| 31 | Hypotension | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 32 | Nervousness | FAERS: 9 | US FAERS | |
| 33 | Syncope | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Agitation | FAERS: 8 | US FAERS | |
| 35 | Alopecia | FAERS: 8 | US FAERS | |
| 36 | Drug screen positive | FAERS: 8 | US FAERS | |
| 37 | Incorrect dose administered | FAERS: 8 | US FAERS | |
| 38 | Memory impairment | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 39 | Myalgia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Weight decreased | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 41 | Chills | FAERS: 7 | US FAERS | |
| 42 | Completed Suicide | FAERS: 7 | US FAERS | |
| 43 | Hypersensitivity | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Hypersomnia | FAERS: 7 | US FAERS | |
| 45 | Impaired work ability | FAERS: 7 | US FAERS | |
| 46 | Lethargy | FAERS: 7 | US FAERS | |
| 47 | Pruritus | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Somnambulism | FAERS: 7 | US FAERS | |
| 49 | Tinnitus | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 50 | Urticaria | FAERS: 7 | US FAERS | |
| 51 | Arthralgia | FAERS: 6 | US FAERS | |
| 52 | Middle insomnia | FAERS: 6 | US FAERS | |
| 53 | Product use in unapproved indication | FAERS: 6 | US FAERS | |
| 54 | Restlessness | FAERS: 6 | US FAERS | |
| 55 | Abdominal discomfort | FAERS: 5 | US FAERS | |
| 56 | Chest discomfort | FAERS: 5 | US FAERS | |
| 57 | Impaired driving ability | FAERS: 5 | US FAERS | |
| 58 | Swelling | FAERS: 5 | US FAERS | |
| 59 | jaundice | FAERS: 5 | US FAERS | |
| 60 | Abasia | FAERS: 4 | US FAERS | |
| 61 | Abdominal Pain | FAERS: 4 | US FAERS | |
| 62 | Amnesia | FAERS: 4 | US FAERS | |
| 63 | Angioedema | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 64 | Burning sensation | FAERS: 4 | US FAERS | |
| 65 | Drug abuse | FAERS: 4 | US FAERS | |
| 66 | Drug administration error | FAERS: 4 | US FAERS | |
| 67 | Drug exposure during pregnancy | FAERS: 4 | US FAERS | |
| 68 | Dysarthria | FAERS: 4 | US FAERS | |
| 69 | Initial insomnia | FAERS: 4 | US FAERS | |
| 70 | Muscle tightness | FAERS: 4 | US FAERS | |
| 71 | Necrosis | FAERS: 4 | US FAERS | |
| 72 | Oropharyngeal pain | FAERS: 4 | US FAERS | |
| 73 | Pregnancy | FAERS: 4 | US FAERS | |
| 74 | Product shape issue | FAERS: 4 | US FAERS | |
| 75 | Tachycardia | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 76 | Therapeutic response unexpected with drug substitution | FAERS: 4 | US FAERS | |
| 77 | Toxicity to various agents | FAERS: 4 | US FAERS | |
| 78 | Wrong drug administered | FAERS: 4 | US FAERS | |
| 79 | Accidental exposure to product by child | FAERS: 3 | US FAERS | |
| 80 | Accidental overdose | FAERS: 3 | US FAERS | |
| 81 | Anger | FAERS: 3 | US FAERS | |
| 82 | Ataxia | FAERS: 3 | US FAERS | |
| 83 | Cardiac Arrest | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Constipation | FAERS: 3 | US FAERS | |
| 85 | Depressed mood | FAERS: 3 | US FAERS | |
| 86 | Diplopia | FAERS: 3 | US FAERS | |
| 87 | Drug screen false positive | FAERS: 3 | US FAERS | |
| 88 | Dry skin | FAERS: 3 | US FAERS | |
| 89 | Dysgeusia | FAERS: 3 | US FAERS | |
| 90 | Dysuria | FAERS: 3 | US FAERS | |
| 91 | Enuresis | FAERS: 3 | US FAERS | |
| 92 | Euphoric mood | FAERS: 3 | US FAERS | |
| 93 | Extra dose administered | FAERS: 3 | US FAERS | |
| 94 | Eye pain | FAERS: 3 | US FAERS | |
| 95 | Mental status changes | FAERS: 3 | US FAERS | |
| 96 | Nocturia | FAERS: 3 | US FAERS | |
| 97 | Product dispensing error | FAERS: 3 | US FAERS | |
| 98 | Product taste abnormal | FAERS: 3 | US FAERS | |
| 99 | Product use complaint | FAERS: 3 | US FAERS | |
| 100 | Respiratory arrest | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | treatment failure | FAERS: 3 | US FAERS | |
| 102 | Activities of daily living impaired | FAERS: 2 | US FAERS | |
| 103 | Acute myocardial infarction | FAERS: 2 | US FAERS | |
| 104 | Adverse event | FAERS: 2 | US FAERS | |
| 105 | Alanine Aminotransferase Increased | FAERS: 2 | US FAERS | |
| 106 | Apathy | FAERS: 2 | US FAERS | |
| 107 | Apparent death | FAERS: 2 | US FAERS | |
| 108 | Aspartate Aminotransferase Increased | FAERS: 2 | US FAERS | |
| 109 | Back Pain | FAERS: 2 | US FAERS | |
| 110 | Blood urine present | FAERS: 2 | US FAERS | |
| 111 | Bone pain | FAERS: 2 | US FAERS | |
| 112 | Bradycardia | FAERS: 2 | US FAERS | |
| 113 | Disturbance in sexual arousal | FAERS: 2 | US FAERS | |
| 114 | Drug Dependence | FAERS: 2 | US FAERS | |
| 115 | Drug effect delayed | FAERS: 2 | US FAERS | |
| 116 | Drug prescribing error | FAERS: 2 | US FAERS | |
| 117 | Dyspepsia | FAERS: 2 | US FAERS | |
| 118 | Dystonia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 119 | Erythema | FAERS: 2 | US FAERS | |
| 120 | Flushing | FAERS: 2 | US FAERS | |
| 121 | Foreign body sensation in eyes | FAERS: 2 | US FAERS | |
| 122 | Head titubation | FAERS: 2 | US FAERS | |
| 123 | Hepatitis | FAERS: 2 | US FAERS | |
| 124 | Inappropriate schedule of drug administration | FAERS: 2 | US FAERS | |
| 125 | Incontinence | FAERS: 2 | US FAERS | |
| 126 | Joint swelling | FAERS: 2 | US FAERS | |
| 127 | Mental impairment | FAERS: 2 | US FAERS | |
| 128 | Mood swings | FAERS: 2 | US FAERS | |
| 129 | Neck Pain | FAERS: 2 | US FAERS | |
| 130 | Neuralgia | FAERS: 2 | US FAERS | |
| 131 | Neutropenia | FAERS: 2 | US FAERS | |
| 132 | Night sweats | FAERS: 2 | US FAERS | |
| 133 | Poor quality drug administered | FAERS: 2 | US FAERS | |
| 134 | Poor quality sleep | FAERS: 2 | US FAERS | |
| 135 | Product size issue | FAERS: 2 | US FAERS | |
| 136 | Product use issue | FAERS: 2 | US FAERS | |
| 137 | Psoriasis | FAERS: 2 | US FAERS | |
| 138 | Pustular psoriasis | FAERS: 2 | US FAERS | |
| 139 | Restless Legs Syndrome | FAERS: 2 | US FAERS | |
| 140 | Sinusitis | FAERS: 2 | US FAERS | |
| 141 | Sleep-related eating disorder | FAERS: 2 | US FAERS | |
| 142 | Therapeutic response unexpected | FAERS: 2 | US FAERS | |
| 143 | Thrombosis | FAERS: 2 | US FAERS | |
| 144 | Tooth Loss | FAERS: 2 | US FAERS | |
| 145 | Transcription medication error | FAERS: 2 | US FAERS | |
| 146 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 147 | Urinary Incontinence | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 148 | Wrong technique in drug usage process | FAERS: 2 | US FAERS | |
| 149 | Wrong technique in product usage process | FAERS: 2 | US FAERS | |
| 150 | Agoraphobia | FAERS: 1 | US FAERS | |
| 151 | Agranulocytosis | FAERS: 1 | US FAERS | |
| 152 | Akathisia | FAERS: 1 | US FAERS | |
| 153 | Akinesia | FAERS: 1 | US FAERS | |
| 154 | Alcohol poisoning | FAERS: 1 | US FAERS | |
| 155 | Amputation of penis | FAERS: 1 | US FAERS | |
| 156 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 157 | Anorexia | FAERS: 1 | US FAERS | |
| 158 | Aphasia | FAERS: 1 | US FAERS | |
| 159 | Asthenopia | FAERS: 1 | US FAERS | |
| 160 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 161 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 162 | Benign Prostatic Hyperplasia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 163 | Blood amylase increased | FAERS: 1 | US FAERS | |
| 164 | Blood creatine phosphokinase increased | FAERS: 1 | US FAERS | |
| 165 | Blood phosphorus decreased | FAERS: 1 | US FAERS | |
| 166 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 167 | Blood sodium decreased | FAERS: 1 | US FAERS | |
| 168 | Blood sodium increased | FAERS: 1 | US FAERS | |
| 169 | Bradyphrenia | FAERS: 1 | US FAERS | |
| 170 | Brain Death | FAERS: 1 | US FAERS | |
| 171 | Bronchospasm | FAERS: 1 | US FAERS | |
| 172 | Cardiac ventricular disorder | FAERS: 1 | US FAERS | |
| 173 | Choking sensation | FAERS: 1 | US FAERS | |
| 174 | Chorea | FAERS: 1 | US FAERS | |
| 175 | Chromaturia | FAERS: 1 | US FAERS | |
| 176 | Clumsiness | FAERS: 1 | US FAERS | |
| 177 | Cold sweat | FAERS: 1 | US FAERS | |
| 178 | Corpora cavernosa surgery | FAERS: 1 | US FAERS | |
| 179 | Crying | FAERS: 1 | US FAERS | |
| 180 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 181 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 182 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 183 | Diabetic Autonomic Neuropathy | FAERS: 1 | US FAERS | |
| 184 | Disease recurrence | FAERS: 1 | US FAERS | |
| 185 | Drug Tolerance | FAERS: 1 | US FAERS | |
| 186 | Drug abuser | FAERS: 1 | US FAERS | |
| 187 | Drug effect variable | FAERS: 1 | US FAERS | |
| 188 | Drug level increased | FAERS: 1 | US FAERS | |
| 189 | Drug resistance | FAERS: 1 | US FAERS | |
| 190 | Drug toxicity | FAERS: 1 | US FAERS | |
| 191 | Early satiety | FAERS: 1 | US FAERS | |
| 192 | Eczema | FAERS: 1 | US FAERS | |
| 193 | Elbow deformity | FAERS: 1 | US FAERS | |
| 194 | Electrocardiogram abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 195 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 196 | Emotional distress | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 197 | Epistaxis | FAERS: 1 | US FAERS | |
| 198 | Feeling of body temperature change | FAERS: 1 | US FAERS | |
| 199 | Foreign body in respiratory tract | FAERS: 1 | US FAERS | |
| 200 | Foreign body trauma | FAERS: 1 | US FAERS | |
| 201 | Gastritis | FAERS: 1 | US FAERS | |
| 202 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 203 | Genital injury | FAERS: 1 | US FAERS | |
| 204 | Glaucoma | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 205 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 206 | Head discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 207 | Hormone level abnormal | FAERS: 1 | US FAERS | |
| 208 | Hostility | FAERS: 1 | US FAERS | |
| 209 | Hyperacusis | FAERS: 1 | US FAERS | |
| 210 | Hyperventilation | FAERS: 1 | US FAERS | |
| 211 | Hypervigilance | FAERS: 1 | US FAERS | |
| 212 | Hypokinesia | FAERS: 1 | US FAERS | |
| 213 | Hypomania | FAERS: 1 | US FAERS | |
| 214 | Hypoperfusion | FAERS: 1 | US FAERS | |
| 215 | Hypophagia | FAERS: 1 | US FAERS | |
| 216 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 217 | Inappropriate affect | FAERS: 1 | US FAERS | |
| 218 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 219 | Incoherent | FAERS: 1 | US FAERS | |
| 220 | Infection | FAERS: 1 | US FAERS | |
| 221 | Injury asphyxiation | FAERS: 1 | US FAERS | |
| 222 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 223 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 224 | Intercepted medication error | FAERS: 1 | US FAERS | |
| 225 | Intestinal Perforation | FAERS: 1 | US FAERS | |
| 226 | Lactation Disorder | FAERS: 1 | US FAERS | |
| 227 | Laziness | FAERS: 1 | US FAERS | |
| 228 | Limb discomfort | FAERS: 1 | US FAERS | |
| 229 | Limb injury | FAERS: 1 | US FAERS | |
| 230 | Lip swelling | FAERS: 1 | US FAERS | |
| 231 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 232 | Lupus-like syndrome | FAERS: 1 | US FAERS | |
| 233 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 234 | Medication residue | FAERS: 1 | US FAERS | |
| 235 | Multiple allergies | FAERS: 1 | US FAERS | |
| 236 | Multiple sclerosis relapse | FAERS: 1 | US FAERS | |
| 237 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 238 | Musculoskeletal stiffness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 239 | Mydriasis | FAERS: 1 | US FAERS | |
| 240 | Myopia | FAERS: 1 | US FAERS | |
| 241 | Myositis | FAERS: 1 | US FAERS | |
| 242 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 243 | Negative thoughts | FAERS: 1 | US FAERS | |
| 244 | Nephrolithiasis | FAERS: 1 | US FAERS | |
| 245 | Neutrophil count decreased | FAERS: 1 | US FAERS | |
| 246 | Nipple pain | FAERS: 1 | US FAERS | |
| 247 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 248 | Norepinephrine increased | FAERS: 1 | US FAERS | |
| 249 | Pallor | FAERS: 1 | US FAERS | |
| 250 | Pancreatic Neoplasm | FAERS: 1 | US FAERS | |
| 251 | Pancreatic enzymes increased | FAERS: 1 | US FAERS | |
| 252 | Pancreatitis | FAERS: 1 | US FAERS | |
| 253 | Paranoia | FAERS: 1 | US FAERS | |
| 254 | Pelvic venous thrombosis | FAERS: 1 | US FAERS | |
| 255 | Penile necrosis | FAERS: 1 | US FAERS | |
| 256 | Penile swelling | FAERS: 1 | US FAERS | |
| 257 | Peripheral paralysis | FAERS: 1 | US FAERS | |
| 258 | Peritonitis | FAERS: 1 | US FAERS | |
| 259 | Pharmaceutical product counterfeit | FAERS: 1 | US FAERS | |
| 260 | Photophobia | FAERS: 1 | US FAERS | |
| 261 | Pleurisy | FAERS: 1 | US FAERS | |
| 262 | Pneumonia | FAERS: 1 | US FAERS | |
| 263 | Post procedural complication | FAERS: 1 | US FAERS | |
| 264 | Product counterfeit | FAERS: 1 | US FAERS | |
| 265 | Product physical consistency issue | FAERS: 1 | US FAERS | |
| 266 | Product physical issue | FAERS: 1 | US FAERS | |
| 267 | Product prescribing error | FAERS: 1 | US FAERS | |
| 268 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 269 | Product storage error | FAERS: 1 | US FAERS | |
| 270 | Progressive supranuclear palsy | FAERS: 1 | US FAERS | |
| 271 | Psychomotor skills impaired | FAERS: 1 | US FAERS | |
| 272 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 273 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 274 | Pyloric Stenosis | FAERS: 1 | US FAERS | |
| 275 | Quality of life decreased | FAERS: 1 | US FAERS | |
| 276 | Rash erythematous | FAERS: 1 | US FAERS | |
| 277 | Retching | FAERS: 1 | US FAERS | |
| 278 | Sepsis | FAERS: 1 | US FAERS | |
| 279 | Shock | FAERS: 1 | US FAERS | |
| 280 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 281 | Sleep Paralysis | FAERS: 1 | US FAERS | |
| 282 | Sluggishness | FAERS: 1 | US FAERS | |
| 283 | Sopor | FAERS: 1 | US FAERS | |
| 284 | Spinal fusion surgery | FAERS: 1 | US FAERS | |
| 285 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 286 | Stress | FAERS: 1 | US FAERS | |
| 287 | Tablet issue | FAERS: 1 | US FAERS | |
| 288 | Tardive Dyskinesia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 289 | Therapeutic product effect variable | FAERS: 1 | US FAERS | |
| 290 | Throat irritation | FAERS: 1 | US FAERS | |
| 291 | Tobacco user | FAERS: 1 | US FAERS | |
| 292 | Toothache | FAERS: 1 | US FAERS | |
| 293 | Torticollis | FAERS: 1 | US FAERS | |
| 294 | Traumatic Brain Injury | FAERS: 1 | US FAERS | |
| 295 | Unevaluable event | FAERS: 1 | US FAERS | |
| 296 | Upper respiratory tract inflammation | FAERS: 1 | US FAERS | |
| 297 | Upper-airway cough syndrome | FAERS: 1 | US FAERS | |
| 298 | Urinary Retention | FAERS: 1 | US FAERS | |
| 299 | Urinary hesitation | FAERS: 1 | US FAERS | |
| 300 | Urinary tract infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 301 | Urine amphetamine positive | FAERS: 1 | US FAERS | |
| 302 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 303 | Vertigo | FAERS: 1 | US FAERS | |
| 304 | Violence-related symptom | FAERS: 1 | US FAERS | |
| 305 | Visual Impairment | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 306 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 307 | nervous system disorder | FAERS: 1 | US FAERS | |
| 308 | Anhedonia | Canada Vigilance: 1 | Canada Vigilance | |
| 309 | Arthritis | Canada Vigilance: 1 | Canada Vigilance | |
| 310 | Blepharospasm | Canada Vigilance: 2 | Canada Vigilance | |
| 311 | Ear discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 312 | Emergency Care | Canada Vigilance: 1 | Canada Vigilance | |
| 313 | Emotional disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 314 | Hyporeflexia | Canada Vigilance: 1 | Canada Vigilance | |
| 315 | Joint stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 316 | Otitis Media | Canada Vigilance: 1 | Canada Vigilance | |
| 317 | Psychological Trauma | Canada Vigilance: 1 | Canada Vigilance | |
| 318 | Therapeutic response delayed | Canada Vigilance: 1 | Canada Vigilance | |
| 319 | Thirst | Canada Vigilance: 1 | Canada Vigilance | |
| 320 | Ventricular arrhythmia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.